Covestor LTD Regeneron Pharmaceuticals, Inc. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Covestor LTD holds 176 shares of REGN stock, worth $125,382. This represents 0.12% of its overall portfolio holdings.

Number of Shares

176

Previous 202 12.87%

Holding current value

$125,382

Previous $212,000 12.26%

% of portfolio

0.12%

Previous 0.14%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$1024.09 - $1201.76 $26,626 - $31,245	-26 Reduced 12.87%	176 $186,000
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $12,637 - $13,906	14 Added 7.45%	202 $195,000
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $34,883 - $39,676	-45 Reduced 19.31%	188 $166,000
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $33,237 - $40,529	48 Added 25.95%	233 $192,000
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $56,002 - $66,428	-80 Reduced 30.19%	185 $133,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $8,165 - $9,923	-12 Reduced 4.33%	265 $218,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $59,294 - $64,376	-84 Reduced 23.27%	277 $199,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $12,627 - $15,935	22 Added 6.49%	361 $249,000
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $32,352 - $43,591	-59 Reduced 14.82%	339 $201,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $102,955 - $120,828	173 Added 76.89%	398 $279,000
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $122,283 - $150,968	225 New	225 $142,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account